Editas Medicine, Inc.EDITNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank58
3Y CAGR-17.5%
5Y CAGR+14.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-17.5%/yr
vs +13.2%/yr prior
5Y CAGR
+14.8%/yr
Recent deceleration
Acceleration
-30.7pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $134.58M | -52.5% |
| 2024 | $283.47M | +17.5% |
| 2023 | $241.24M | +0.8% |
| 2022 | $239.32M | +12.0% |
| 2021 | $213.64M | +216.1% |
| 2020 | $67.58M | +4.7% |
| 2019 | $64.56M | -55.7% |
| 2018 | $145.66M | +9.0% |
| 2017 | $133.66M | +29.5% |
| 2016 | $103.24M | - |